Konkurencja i konsument · 26/09/1995

Hoechst AG Reaches Proposed Consent Agreement to Settle Antitrust Claims from $7.1 Billion Merger

Hoechst AG, a pharmaceutical firm, has proposed a consent agreement with Biovail Corporation International to settle allegations of unfair business practices arising from its $7.1 billion merger with Marion Merrell Dow, Inc. The agreement would require Hoechst to return confidential information, refrain from using it, and dismiss a patent infringement lawsuit, among other conditions.